Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyn-Stokes respiration

European Heart Journal

Volumn 19, Issue 6, 1998, Pages 922-928

  Staniforth, A D ^a,b   Kinnear, W J M ^a   Starling, R ^a   Hetmanski, D J ^a   Cowley, A J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cheyne Stokes respiration; Heart failure; Oxygen; Sympathetic activity

Indexed keywords

CATECHOLAMINE; CREATININE; NORADRENALIN; OXYGEN;

ADULT; AGED; ARTICLE; CATECHOLAMINE URINE LEVEL; CHEYNE STOKES BREATHING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HEART FAILURE; HUMAN; MORTALITY; NORADRENALIN URINE LEVEL; OXYGEN THERAPY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SOMNOLENCE; SYMPATHETIC TONE; SYMPTOM;

AGED; AROUSAL; CHEYNE-STOKES RESPIRATION; CREATININE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; OXYGEN INHALATION THERAPY; POLYSOMNOGRAPHY; SLEEP STAGES; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032103084     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0861     Document Type: Article

References (35)

1. [1] Cheyne J. A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hospital Reports 1818; 2: 216-22.
2. [2] Javaheri S, Parker TJ, Wexler L et al. Occult sleep disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122: 487-92.
3. [3] Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Resp Crit Care Med 1996; 153: 272-6.
4. [4] Findley LJ, Barth JT, Powers DC, Wilhoit SC, Boyd DG, Suratt PM. Cognitive impairment with obstructive sleep apnoea and associated hypoxaemia. Chest 1986; 90: 686-90.
5. [5] Bedard MA, Montplaisir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnoea syndrome: pathogenesis of neuropsychological deficits. J Clin Exper Neuropsychology 1991; 13: 950-64.
6. [6] Findlay L, Unverzagt M, Guchu R, Fabrizio M, Bruckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnoea or narcolepsy. Chest 1995; 108: 619-24.
7. [7] Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111: 777-82.
8. [8] Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston IDA, Kinnear WJM. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995; 73: 237-41.
9. [9] Andreas S, Clemens C, Sandholzer H, Figulla HR, Kreuzer H. Improvement in exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27: 1486-90.
10. [10] Franklin KA, Eriksson P, Sahlin C, Lungdren R. Reversal of central sleep apnoea with oxygen. Chest 1997; 111: 163-9.
11. [11] Naughton MT, Benard DC, Liu P, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnoea. Am J Resp Crit Care Med 1995; 152: 473-9.
12. [12] Rechtschaffen A, Kales A. A manual of standardised terminology, techniques, and scoring system for sleep stages of human subjects. Publication No. 204. National Institutes of Health, Washington, DC.
13. [13] Gronwall DMA. Paced auditory serial addition task: a measure of recovery from concussion. Percept Motor Skills 1977; 44: 367-73.
14. [14] Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery. Tuscon, Neuropsychology Press, 1985.
15. [15] Wilkinson RT, Houghton D. Portable four choice reaction time test with magnetic tape memory. Behav Res Methods Instruments 1975; 7: 441-6.
16. [16] Findley L, Fabrizio M, Knight H, Norcross B, LaForte A, Suratt P. Driving simulator performance in patients with sleep apnoea. Am Rev Respir Dis 1989; 140: 529-30.
17. [17] Johns MW. Daytime sleepiness, snoring and obstructive sleep apnoea. The Epworth sleepiness scale. Chest 1993; 103: 30-6.
18. [18] Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Br Heart J 1994; 72: 226-30.
19. [19] Hampton JR, van Veldhuisen DJ, Kleber FX et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet 1997; 349: 971-7.
20. [20] Brown MJ, Causon RC, Barnes VF, Brennan P, Barnes G, Greenberg G. Urinary catecholamines in essential hypertension: results of 24 hour urinary catecholamine analysis from patients in the Medical Research Council trial for mild hypertension and from matched controls. Q J Med 1985; 57: 637-51.
21. [21] Macdonald IA, Lake DM. An improved technique for extracting catecholamines from body fluids. J Neuroscience Methods 1985; 13: 239-48.
22. [22] Voto LS, Hetmanski DJ, Broughton Pipkin F. Determinants of fetal and maternal atrial natriuretic peptide concentrations at delivery in man. Br J Obs Gynae 1990; 97: 1123-9.
23. [23] Martin SE, Engleman HM, Deary IJ, Douglas NJ. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 1996; 153: 1328-32.
24. [24] Khoo MCK, Gottschalk A, Pack AJ. Sleep induced periodic breathing and apnoea: a theoretical study. J Appl Physiol 1991; 70: 2014-24.
25. [25] Kimoff RJ, Cheong TH, Olha AE et al. Mechanisms of apnoea termination in obstructive sleep apnoea. Am J Resp Crit Care Med 1994; 149: 707-14.
26. [26] van de Borne P, Abou-Assaly C, Oren R, Somers VK. Cheyne-Stokes breathing increases muscle sympathetic nerve activity in severe heart failure. Eur Heart J 1997; 18 (Abstr Suppl): 576.
27. [27] Andreas S, Wenzel RR, Luscher TF, Noll G. Effects of oxygen on muscle sympathetic activity in patients with congestive heart failure. Eur Heart J 1997; 18 (Abstr Suppl): 289.
28. [28] Krieger J, Laks L, Wilcox I et al. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci 1989; 77: 407-11.
29. [29] Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Haemodynamic effect of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996; 27: 353-7.
30. [30] Biberdorf DJ, Steens R, Millar TW, Kryger MH. Benzodiazepines in congestive heart failure: effects of Temazepam on arousability and Cheyne-Stokes respiration. Sleep 1993; 16: 529-38.
31. [31] Javaheri S, Parker TJ, Wexler L, Liming JD, Lindover P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335: 562-7
32. [32] De Hoyos A, Liu P, Benard DC, Bradley TD. Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular functions. Clin Sci 1995; 88: 173-8.
33. [33] Naughton MT, Rahman A, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725-31.
34. 2 in heart failure. Am J Resp Crit Care Med 1994; 150: 1598-604.
35. [35] Naughton MT, Liu PP, Benard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Resp Crit Care Med 1995; 151: 92-7